Go to
http(s)://medscape.com/viewarticle/969733
Information preview:
The pathologic complete response rate was 24 versus 2.2 with chemotherapy alone.
Tags: lung cancer, lung carcinoma, cancer (lung), non-small cell lung cancer, nsclc, cancer, malignant neoplasia, carcinoma, chemotherapy, neoadjuvant, combination chemotherapy
The referring site you are going to visit is not controlled by us, so please remember not to enter your private information unless you are sure this is not scam. Also be sure to access or download only from sites you trust and remember to always check the site's Terms & Privacy first.
Before access please be sure this is the address you want to go.
Check the box if you have read and agree to our Terms & Privacy.
We may use cookies to give you the best experience. If you do nothing we'll assume that it's ok.
The information forward from this site may be provided by third parties. We will not be responsible with outside links, contents from source of information, methods of using, using or consequence of contents with users. All direct or indirect risk related to use of this site is borne entirely by you, the user.
We use advertising companies as Google AdSense, to serve ads when you visit our website. These companies may use information (not including your name, address, email address, or telephone number) about your visits to this and other websites in order to provide advertisements about goods and services of interest to you. If you would like more information about this practice and to know your choices about not having this information used by these companies, see https://policies.google.com/technologies/ads.